MS4A12 and malignant colon neoplasm: Nandy et al. (36) again verified that SFTPD with elevated serum expression level was associated with chronic obstructive pulmonary disease and MS4A12 was a novel colon cancer-associated factor, the expression of this gene was dependent on CDX2.